Vemurafenib and concomitant stereotactic radiation for the treatment of melanoma with spinal metastases: A case report

Reports of Practical Oncology and Radiotherapy

Volumn 21, Issue 1, 2016, Pages 76-80

  Stefan, Dinu ^a   Popotte, Hosni ^a   Stefan, Andreea Raluca ^b,c   Tesniere, Audrey ^b,c   Tomaszewski, Aurélie ^a   Lesueur, Paul ^a   Habrand, Jean Louis ^a   Verneuil, Laurence ^b,c  

^a Calvados Cancer General Registry   (France)

^b CAEN UNIVERSITY HOSPITAL   (France)

^c UNIVERSITÉ DE CAEN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

VEMURAFENIB;

ADULT; ARTICLE; BRAF GENE; BRAIN METASTASIS; CASE REPORT; CYBERKNIFE; DOSIMETRY; DRUG WITHDRAWAL; HUMAN; MALE; MELANOMA; MIDDLE AGED; MUCOSAL DISEASE; NEUROTOXICITY; ONCOGENE; RADIATION DOSE FRACTIONATION; SKIN TOXICITY; SPINE METASTASIS; STEREOTACTIC BODY RADIATION THERAPY; TREATMENT RESPONSE;

EID: 84953638509     PISSN: 15071367     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rpor.2015.07.005     Document Type: Article

References (16)

1. Homer M.J., Ries L.A.G., Krapcho M. SEER Cancer Statistics Review, 1975-2006 2009, National Cancer Institute, Bethesda, MD, Available from: http://seer.cancer.gov/csr/1975_2006.
2. Remontet L., Esteve J., Bouvier A.M., et al. Cancer incidence and mortality in France over the period 1978-2000. Rev Epidemiol Sante Publique 2003, 51(February (1 Pt 1)):3-30.
3. Belot A., Grosclaude P., Bossard N., et al. Cancer incidence and mortality in France over the period 1980-2005. Rev Epidemiol Sante Publique 2008, 56(June (3)):159-175.
4. HAS Stratégie de diagnostic précoce du mélanome October 2006, Rapport d'évaluation.
5. Korn E.L., Liu P.Y., Lee S.J., et al. Meta-analysis of phase II cooperative group trials in metastatic stage IV melanoma to determine progression-free and overall survival benchmarks for future phase II trials. J Clin Oncol 2008, 26(February (4)):527-534.
6. Ascierto P.A., Grimaldi A.M., Curti B., et al. Future perspectives in melanoma research. Meeting report from the "Melanoma research: a bridge from Naples to the World. Napoli, December 5th-6th 2011". J Transl Med 2012, 10:83.
7. Gerszten P.C., Burton S.A., Ozhasoglu C., Welch W.C. Radiosurgery for spinal metastases: clinical experience in 500 cases from a single institution. Spine (Phila Pa 1976) 2007, 32(January (2)):193-199.
8. Wong D.A., Fornasier V.L., MacNab I. Spinal metastases: the obvious, the occult, and the impostors. Spine (Phila Pa 1976) 1990, 15(January (1)):1-4.
9. Barnholtz-Sloan J.S., Sloan A.E., Davis F.G., Vigneau F.D., Lai P., Sawaya R.E. Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System. J Clin Oncol 2004, 22(July (14)):2865-2872.
10. Schouten L.J., Rutten J., Huveneers H.A., Twijnstra A. Incidence of brain metastases in a cohort of patients with carcinoma of the breast, colon, kidney, and lung and melanoma. Cancer 2002, 94(May (10)):2698-2705.
11. Amer M.H., Al-Sarraf M., Baker L.H., Vaitkevicius V.K. Malignant melanoma and central nervous system metastases: incidence, diagnosis, treatment and survival. Cancer 1978, 42(August (2)):660-668.
12. Patel J.K., Didolkar M.S., Pickren J.W., Moore R.H. Metastatic pattern of malignant melanoma. A study of 216 autopsy cases. Am J Surg 1978, 135(June (6)):807-810.
13. Flaherty K.T., Puzanov I., Kim K.B., et al. Inhibition of mutated, activated BRAF in metastatic melanoma. N Engl J Med 2010, 363(August (9)):809-819.
14. Ongoing trial A Multicenter Phase II Study of ipilimumab combined with a Stereotactic Radiosurgery in Melanoma Patients with Brain Metastases. Protocol Number: 2011_48, EUDRACT Number: 2012-000852-32 2013.
15. Sambade M.J., Peters E.C., Thomas N.E., Kaufmann W.K., Kimple R.J., Shields J.M. Melanoma cells show a heterogeneous range of sensitivity to ionizing radiation and are radiosensitized by inhibition of B-RAF with PLX-4032. Radiother Oncol 2011, 98(March (3)):394-399.
16. Anker C.J. Severe liver and skin toxicity after radiation and vemurafenib in metastatic melanoma. J Clin Oncol 2013, 31(June (17)):e283-e287.